Manufacturer of Controlled Substances; Notice of Application, 25376 [2011-10913]
Download as PDF
<![CDATA[
25376
Federal Register / Vol. 76, No. 86 / Wesnesday, May 4, 2011 / Notices
the following basic classes of controlled
substances:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Ecgonine (9180) ...........................
Morphine (9300) ...........................
I
II
II
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacture of reagents
and drug calibrator/controls which are
DEA exempt products.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 5, 2011.
Dated: April 25, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–10861 Filed 5–3–11; 8:45 am]
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 5, 2011,
Johnson Matthey Pharma Services, 70
Flagship Drive, North Andover,
Massachusetts 01845, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Schedule
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Hydrocodone (9193) .....................
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 5, 2011.
Dated: April 28, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–10913 Filed 5–3–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated January 26, 2011, and
published in the Federal Register on
February 3, 2011, 76 FR 6159, Johnson
Matthey Inc., Pharmaceuticals
Materials, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
Gamma Hydroxybutyric Acid (2010) ...................................................................................................................................................
Amphetamine (1100) ...........................................................................................................................................................................
Methylphenidate (1724) .......................................................................................................................................................................
Codeine (9050) ....................................................................................................................................................................................
Oxycodone (9143) ...............................................................................................................................................................................
Hydrocodone (9193) ............................................................................................................................................................................
Morphine (9300) ..................................................................................................................................................................................
Thebaine (9333) ..................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers. The Thebaine
(9333) will also be used to manufacture
other controlled substances for sale in
bulk to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
VerDate Mar<15>2010
17:45 May 03, 2011
Jkt 223001
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 26, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–10865 Filed 5–3–11; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
I
II
II
II
II
II
II
II
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2011–0059]
Occupational Exposure to Hazardous
Chemicals in Laboratories Standard;
Extension of the Office of Management
and Budget’s (OMB) Approval of
Information Collection (Paperwork)
Requirements
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Request for public comments.
AGENCY:
OSHA solicits public
comments concerning its proposal to
extend OMB approval of the
SUMMARY:
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 76, Number 86 (Wednesday, May 4, 2011)]
[Notices]
[Page 25376]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10913]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 5, 2011, Johnson
Matthey Pharma Services, 70 Flagship Drive, North Andover,
Massachusetts 01845, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Hydrocodone (9193)......................... II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 5, 2011.
Dated: April 28, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-10913 Filed 5-3-11; 8:45 am]
BILLING CODE 4410-09-P
